These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10876313)

  • 21. Cytoplasmic/nuclear expression without mutation of exon 3 of the beta-catenin gene is frequent in the development of the neoplasm of the uterine cervix.
    Shinohara A; Yokoyama Y; Wan X; Takahashi Y; Mori Y; Takami T; Shimokawa K; Tamaya T
    Gynecol Oncol; 2001 Sep; 82(3):450-5. PubMed ID: 11520139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synchronous endometrioid carcinomas of the uterine corpus and ovary: alterations in the beta-catenin (CTNNB1) pathway are associated with independent primary tumors and favorable prognosis.
    Irving JA; Catasús L; Gallardo A; Bussaglia E; Romero M; Matias-Guiu X; Prat J
    Hum Pathol; 2005 Jun; 36(6):605-19. PubMed ID: 16021566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors.
    Tissier F; Cavard C; Groussin L; Perlemoine K; Fumey G; Hagneré AM; René-Corail F; Jullian E; Gicquel C; Bertagna X; Vacher-Lavenu MC; Perret C; Bertherat J
    Cancer Res; 2005 Sep; 65(17):7622-7. PubMed ID: 16140927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beta-catenin and E-cadherin expression patterns in high-grade endometrial carcinoma are associated with histological subtype.
    Schlosshauer PW; Ellenson LH; Soslow RA
    Mod Pathol; 2002 Oct; 15(10):1032-7. PubMed ID: 12379748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of the E-cadherin-catenin complex in lung neuroendocrine tumours.
    Clavel CE; Nollet F; Berx G; Tejpar S; Nawrocki-Raby B; Kaplan HH; van Roy FM; Birembaut PL
    J Pathol; 2001 May; 194(1):20-6. PubMed ID: 11329137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histologic type, organ of origin, and Wnt pathway status: effect on gene expression in ovarian and uterine carcinomas.
    Shedden KA; Kshirsagar MP; Schwartz DR; Wu R; Yu H; Misek DE; Hanash S; Katabuchi H; Ellenson LH; Fearon ER; Cho KR
    Clin Cancer Res; 2005 Mar; 11(6):2123-31. PubMed ID: 15788657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. beta-catenin expression, DNA ploidy and clinicopathological features in ovarian cancer: a study in 253 patients.
    Kildal W; Risberg B; Abeler VM; Kristensen GB; Sudbø J; Nesland JM; Danielsen HE
    Eur J Cancer; 2005 May; 41(8):1127-34. PubMed ID: 15911235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic alteration of the beta-catenin gene (CTNNB1) in human lung cancer and malignant mesothelioma and identification of a new 3p21.3 homozygous deletion.
    Shigemitsu K; Sekido Y; Usami N; Mori S; Sato M; Horio Y; Hasegawa Y; Bader SA; Gazdar AF; Minna JD; Hida T; Yoshioka H; Imaizumi M; Ueda Y; Takahashi M; Shimokata K
    Oncogene; 2001 Jul; 20(31):4249-57. PubMed ID: 11464291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel candidate targets of beta-catenin/T-cell factor signaling identified by gene expression profiling of ovarian endometrioid adenocarcinomas.
    Schwartz DR; Wu R; Kardia SL; Levin AM; Huang CC; Shedden KA; Kuick R; Misek DE; Hanash SM; Taylor JM; Reed H; Hendrix N; Zhai Y; Fearon ER; Cho KR
    Cancer Res; 2003 Jun; 63(11):2913-22. PubMed ID: 12782598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of the beta-catenin gene in primary hepatocellular carcinomas by somatic alterations involving exon 3.
    Miyoshi Y; Iwao K; Nagasawa Y; Aihara T; Sasaki Y; Imaoka S; Murata M; Shimano T; Nakamura Y
    Cancer Res; 1998 Jun; 58(12):2524-7. PubMed ID: 9635572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beta-catenin and cyclin D1 expression in human hepatocellular carcinoma.
    Ueta T; Ikeguchi M; Hirooka Y; Kaibara N; Terada T
    Oncol Rep; 2002; 9(6):1197-203. PubMed ID: 12375019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of beta-catenin and E-cadherin in the adenoma-carcinoma sequence of the stomach.
    Kim HS; Hong EK; Park SY; Kim WH; Lee HS
    Anticancer Res; 2003; 23(3C):2863-8. PubMed ID: 12926124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. beta- Catenin mutations and aberrant nuclear expression during endometrial tumorigenesis.
    Saegusa M; Hashimura M; Yoshida T; Okayasu I
    Br J Cancer; 2001 Jan; 84(2):209-17. PubMed ID: 11161379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutation of beta-catenin and its protein accumulation in solid and cystic tumor of the pancreas associated with metastasis.
    Miao J; Kusafuka T; Kuroda S; Yoneda A; Zhou Z; Okada A
    Int J Mol Med; 2003 Apr; 11(4):461-4. PubMed ID: 12632098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beta-catenin mutations in human prostate cancer.
    Voeller HJ; Truica CI; Gelmann EP
    Cancer Res; 1998 Jun; 58(12):2520-3. PubMed ID: 9635571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beta-catenin accumulation and mutation of the CTNNB1 gene in hepatoblastoma.
    Bläker H; Hofmann WJ; Rieker RJ; Penzel R; Graf M; Otto HF
    Genes Chromosomes Cancer; 1999 Aug; 25(4):399-402. PubMed ID: 10398436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nuclear accumulation of beta-catenin protein in Wilms' tumours.
    Koesters R; Niggli F; von Knebel Doeberitz M; Stallmach T
    J Pathol; 2003 Jan; 199(1):68-76. PubMed ID: 12474228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beta-catenin mutations in biliary tract cancers: a population-based study in China.
    Rashid A; Gao YT; Bhakta S; Shen MC; Wang BS; Deng J; Fraumeni JF; Hsing AW
    Cancer Res; 2001 Apr; 61(8):3406-9. PubMed ID: 11309300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cribriform-morular variant of papillary thyroid carcinoma: a pathological and molecular genetic study with evidence of frequent somatic mutations in exon 3 of the beta-catenin gene.
    Xu B; Yoshimoto K; Miyauchi A; Kuma S; Mizusawa N; Hirokawa M; Sano T
    J Pathol; 2003 Jan; 199(1):58-67. PubMed ID: 12474227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathogenetic pathways in ovarian endometrioid adenocarcinoma: a molecular study of 29 cases.
    Geyer JT; López-García MA; Sánchez-Estevez C; Sarrió D; Moreno-Bueno G; Franceschetti I; Palacios J; Oliva E
    Am J Surg Pathol; 2009 Aug; 33(8):1157-63. PubMed ID: 19542870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.